Matsumura N, Tsuruta T, Goto-Koshino Y, Mizukami K, Aoi T, Yamada R
Front Vet Sci. 2025; 12:1535446.
PMID: 40046420
PMC: 11880205.
DOI: 10.3389/fvets.2025.1535446.
Trojovsky K, Seidl M, Babor F, Ehl S, Lee-Kirsch M, Friedt M
Front Pediatr. 2025; 12():1516017.
PMID: 39840313
PMC: 11746893.
DOI: 10.3389/fped.2024.1516017.
Adachi Y, Terakura S, Osaki M, Okuno Y, Sato Y, Sagou K
Nat Commun. 2024; 15(1):10376.
PMID: 39658572
PMC: 11631977.
DOI: 10.1038/s41467-024-54794-x.
Omer A, Kumar S, Soderquist B, Melik W, Bengtsson T, Khalaf H
Viruses. 2024; 16(11).
PMID: 39599884
PMC: 11599086.
DOI: 10.3390/v16111770.
Wang A, Li T, Mao Y, Gao M, Shu S, Xia C
BMC Pulm Med. 2024; 24(1):552.
PMID: 39497173
PMC: 11533424.
DOI: 10.1186/s12890-024-03371-5.
Deep learning analysis of histopathological images predicts immunotherapy prognosis and reveals tumour microenvironment features in non-small cell lung cancer.
Wang Y, Ju X, Hua R, Chen J, Dai X, Liu L
Br J Cancer. 2024; 131(11):1833-1845.
PMID: 39455880
PMC: 11589918.
DOI: 10.1038/s41416-024-02856-8.
Denervation‑induced NRG3 aggravates muscle heterotopic ossification via the ErbB4/PI3K/Akt signaling pathway.
Ma L, Kang X, Tan J, Wang Y, Liu X, Tang H
Mol Med Rep. 2024; 31(1).
PMID: 39450542
PMC: 11529186.
DOI: 10.3892/mmr.2024.13374.
PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target.
Yang X, Liu C, Lei Y, Liu Z, Zhu B, Zhao D
Front Immunol. 2024; 15:1443784.
PMID: 39372407
PMC: 11449710.
DOI: 10.3389/fimmu.2024.1443784.
A cancer-associated fibroblasts related risk score (CAFscore) helps to guide prognosis and personal treatment for Glioblastoma.
Wu L, Liu Q, Li G, Shi W, Peng W
Discov Oncol. 2024; 15(1):420.
PMID: 39254749
PMC: 11387281.
DOI: 10.1007/s12672-024-01314-4.
Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain.
Byun H, Singh G, Xu W, Das P, Reyes A, Battenhouse A
PLoS Pathog. 2024; 20(8):e1012505.
PMID: 39208378
PMC: 11389910.
DOI: 10.1371/journal.ppat.1012505.
Case Report: Common variable immunodeficiency phenotype and granulomatous-lymphocytic interstitial lung disease with a novel SOCS1 variant.
Caldirola M, Daiana E, Gomez Raccio A, Garcia A, Bernacchia A, Medin M
Front Pediatr. 2024; 12:1423858.
PMID: 39005503
PMC: 11239428.
DOI: 10.3389/fped.2024.1423858.
Identification of immune-associated biomarkers of diabetes nephropathy tubulointerstitial injury based on machine learning: a bioinformatics multi-chip integrated analysis.
Wang L, Su J, Liu Z, Ding S, Li Y, Hou B
BioData Min. 2024; 17(1):20.
PMID: 38951833
PMC: 11218417.
DOI: 10.1186/s13040-024-00369-x.
One gene to rule them all - clinical perspectives of a potent suppressor of cytokine signaling - SOCS1.
Korholz J, Chen L, Strauss T, Schuetz C, Dalpke A
Front Immunol. 2024; 15:1385190.
PMID: 38711523
PMC: 11070515.
DOI: 10.3389/fimmu.2024.1385190.
Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins.
Cianciulli A, Calvello R, Porro C, Lofrumento D, Panaro M
Cells. 2024; 13(6.
PMID: 38534350
PMC: 10968894.
DOI: 10.3390/cells13060505.
Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease.
Tine M, Balestro E, Carpi S, Neri T, Biondini D, Conti M
Front Immunol. 2024; 15:1320077.
PMID: 38533493
PMC: 10963451.
DOI: 10.3389/fimmu.2024.1320077.
Immune Factors, Immune Cells and Inflammatory Diseases.
Ward A
Int J Mol Sci. 2024; 25(4).
PMID: 38397094
PMC: 10889257.
DOI: 10.3390/ijms25042417.
Identification of Hit Compounds Using Artificial Intelligence for the Management of Allergic Diseases.
Byun J, Tai J, Kim B, Kim J, Jung S, Lee J
Int J Mol Sci. 2024; 25(4).
PMID: 38396957
PMC: 10889320.
DOI: 10.3390/ijms25042280.
Human alveolar macrophages display marked hypo-responsiveness to IFN-γ in both proteomic and gene expression analysis.
Thiel B, Lundberg K, Schlatzer D, Jarvela J, Li Q, Shaw R
PLoS One. 2024; 19(2):e0295312.
PMID: 38300916
PMC: 10833554.
DOI: 10.1371/journal.pone.0295312.
The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma.
Shukla A, Khan M, Cayarga A, Namvarpour M, Chowdhury M, Levesque D
Cancers (Basel). 2024; 16(2).
PMID: 38254783
PMC: 10814246.
DOI: 10.3390/cancers16020292.
SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation.
Yan D, Li G, Yuan Y, Li H, Cao H, Dai Y
Cancer Gene Ther. 2023; 31(3):397-409.
PMID: 38102464
DOI: 10.1038/s41417-023-00710-2.